Arrhythmogenic right ventricular dysplasia epidemiology and demographics: Difference between revisions
No edit summary |
|||
Line 14: | Line 14: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Cardiology]] | |||
[[Category:Electrophysiology]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 02:13, 23 September 2012
Arrhythmogenic right ventricular dysplasia Microchapters |
Differentiating Arrhythmogenic right ventricular dysplasia from other Diseases |
---|
Diagnosis |
Treatment |
Arrhythmogenic right ventricular dysplasia epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Arrhythmogenic right ventricular dysplasia epidemiology and demographics |
FDA on Arrhythmogenic right ventricular dysplasia epidemiology and demographics |
CDC on Arrhythmogenic right ventricular dysplasia epidemiology and demographics |
Arrhythmogenic right ventricular dysplasia epidemiology and demographics in the news |
Blogs onArrhythmogenic right ventricular dysplasia epidemiology and demographics |
Directions to Hospitals Treating Arrhythmogenic right ventricular dysplasia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
ARVD is rare, is observed more commonly in males, and accounts for 17% of all sudden cardiac deaths in the young.
Incidence
The incidence of ARVD is about 1/10,000 in the general population in the United States, although some studies have suggested that it may be as common as 1/1,000. It accounts for up to 17% of all sudden cardiac deaths in the young. In Italy, the incidence is 40/10,000, making it the most common cause of sudden cardiac death in the young population. It is more common in Northern Italy.
Gender
Male to female ratio of 3:1